MRE11 and EXO1 nucleases degrade reversed forks and elicit MUS81-dependent fork rescue in BRCA2-deficient cells.

Lemaçon D, Jackson J, Quinet A, Brickner JR, Li S, Yazinski S, You Z, Ira G, Zou L, Mosammaparast N, Vindigni A. · 2017

Read MRE11 and EXO1 nucleases degrade reversed forks and elicit MUS81-dependent fork rescue in BRCA2-deficient cells. by Lemaçon D, Jackson J, Quinet A, Brickner JR, Li S, Yazinski S, You Z, Ira G, Zou L, Mosammaparast N, Vindigni A. (2017) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5643552.txt.

Description

Lemaçon and co-authors report a companion study in Nature Communications. It also concerns BRCA proteins and stalled replication forks. Without BRCA protection, the MRE11 nuclease degrades reversed forks. That damage drives sensitivity to chemotherapy. The team combined electron microscopy with DNA fiber methods. They traced exactly how the breakdown starts and proceeds.

CtIP starts MRE11-dependent attack on unprotected regressed arms. The EXO1 nuclease then extends the degradation. Limited cutting creates a tail that MUS81 can cleave. That cleavage enables a rescue route needing POLD3. Rescued forks restart through a break-induced replication process. The pathway held in BRCA2-deficient cells, not BRCA1-deficient ones. The authors propose targeting it to tune drug response.

Catalog record

CREATORLemaçon D, Jackson J, Quinet A, Brickner JR, Li S, Yazinski S, You Z, Ira G, Zou L, Mosammaparast N, Vindigni A.
YEAR2017
COLLECTIONPAPERS
FORMATTXT
FILE SIZE59 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC5643552

Browse the full library · About the Tower of Babel